Jupiter Endovascular secured an oversubscribed Series B financing exceeding $40 million, led by Sonder Capital. The funds will advance clinical trials and commercialization of their TFX technology.

Jupiter Endovascular Appoints Fred Ong as Chief Financial Officer

Launched Jupiter Endovascular, Inc. announces the treatment of the first U.S. patient with the Vertex Pulmonary Embolectomy System, aimed at enhancing endovascular procedures.

Jupiter Endovascular, Inc. announces the treatment of the first U.S. patient with the Vertex Pulmonary Embolectomy System, aimed at enhancing endovascular procedures.

Jupiter Endovascular raised $21M in new financing led by Sonder Capital to fund a pivotal trial for Pulmonary Embolism.

Jupiter Endovascular Appoints Carl J. St. Bernard as Chief Executive Officer

Jupiter Endovascular is a medical technology startup developing the “endoportal procedure,” a new class of endovascular interventions using Endoportal Control to bring the precision and control of direct surgical access to catheter-based therapies. The procedure uses an endoportal device that navigates flexibly through the vasculature via percutaneous access. Once in position, the endoportal devic

Jupiter Endovascular

Funding history

Recent signals